Device tax: Jobs, R&D likely sacrifices in the face of tax burden, survey shows

MassMedic logo

Massachusetts medical device executives forecast job losses and budget-cutting for research & development efforts, as the industry nears the launch date of a 2.3% medical device excise tax.

Half of the 42 senior executives surveyed in the Bay State said they would slash R&D budgets and 25% said they would cut jobs at home and outsource manufacturing to lower-cost areas.

"We warned 2 years ago that medical device companies would be forced to deal with this tax by preparing for job cuts and reductions in R&D spending," MassMEDIC president Tom Sommer said in prepared remarks. "The U.S. leads the world in developing and manufacturing medical products, it doesn’t make sense that on 1 hand the government is promoting exports and manufacturing jobs, while on the other hand it is implementing policies that will cut jobs in this sector and harm its competitive advantage – the development of innovative medical technologies."

Only a quarter of respondents said they had a plan in place to comply with the tax, which goes into effect in 2013. Moody’s Investor Services estimates that the levy could have a net impact of more than $650 million on the 20 med-tech companies it covers.

Nearly 45% of survey participants said they plan to pass on the cost of the tax to their customers by raising prices. Nearly 40% said they would assume the costs internally, according to a press release.

The MassMEDIC survey isn’t the 1st to issue an ominous forecast for the tax, which Cook Group chairman Stephen Ferguson called "a bad idea that will only get worse with time."

Cook blames the tax for its decision to put the kaibosh on plans to build 1 new U.S. factory a year in the U.S.; and orthopedic giants Zimmer Holdings (NYSE:ZMH) and Stryker Corp. (NYSE:SYK) have both announced layoffs directly tied to the expected cost of the revenue tax.

A February survey of 180 device industry executives found that more than half planned to increase prices for their products in order to fully or partially offset the effects of the tax, according to Emergo Group.

Opponents of the tax have found some support for repeal in the GOP-led U.S. House of Representatives, but repeal efforts in the U.S. Senate have been lacking. A vote for repeal is considered highly unlikely, as Democrats aren’t eager to begin taking apart President Obama’s landmark health care reform bill.

Nonetheless, a vote on a repeal measure headed by Rep. Erik Paulsen (R-Minn.) may hit the House floor this year, Paulsen told MassDevice in an exclusive podcast interview. The bill had 228 co-sponsors as of mid-February, more than enough to pass.

Last month, industry lobby AdvaMed revealed plans to frame repeal efforts as tax reform, hoping to divorce the industry’s beef with the legislation from arguments surrounding health care reform.

RSS From Medical Design & Outsourcing

  • Athermal laser machining cuts bioabsorbable polymers and more
    A the recent MD&M East trade show in New York, Norman Noble, discussed the capability of athermal laser manufacturer. The company has developed the Noble S.T.E.A.L.T.H. (System To Enable Ablation Laser Technology Haz-free). The athermal laser machining process was developed to create precise features in any material, including bioabsorbable polymers, shape memory metals and other […]
  • Exciting possibilities for metallic glass in the medical device world
    Researchers are exploring the potential of metallic glass as a versatile, pliable material that is stronger than steel, with a bevy of possible medical device applications. Yale University engineers have discovered a unique method for designing metallic glass nanostructures across a wide range of chemicals, a technique that could have applications for everything from watch […]
  • Strong Precision Technologies’ medical divisions to unify under MedTorque brand
    Strong Precision Technologies announced on July 2, 2015, that its two medical divisions will now go to market under a single brand, MedTorque. The move reflects the increasing integration of the division formerly known as Inland Midwest with MedTorque, its sister division in Kenosha, WI. “We will continue providing our customers with the personalized level of service […]
  • Olympus offers next-day product replacement guarantee for medical devices
    Olympus, a medical and surgical procedures solutions company, announced that it is guaranteeing next-day replacements for surgical equipment at no additional charge. Olympus is the first surgical product manufacturer to offer this type of guarantee. The service became available to customers with an Olympus Full Service Agreement earlier this year. “Canceled procedures can be costly for healthcare facilities […]
  • More accurate prediction on prognosis in multiple myeloma from SkylineDx
    SkylineDx, a biotechnology company specializing in the development and commercialization of genetic tests, is launching its MMprofiler assay. This test enables clinicians to more accurately predict the prognosis of patients with multiple myeloma (bone marrow cancer) than traditional methods. The MMprofiler measures the activity of 92 genes which are directly or indirectly related to the […]
  • Flint Mobile swaps card reader for camera, accept mobile payments anywhere
    Flint Mobile, the swipe-free mobile payments app, has significantly expanded its payment management and loyalty capabilities for small, service-centric businesses, like the ones run by on-the-go medical equipment professionals. The toggle-free mobile technology makes the process quite simple for both parties, as all transactions are conducted through the mobile device’s camera without the need of any external […]
  • Should scientists be allowed to genetically alter human embryos?
    Scientists have at their disposal, a way to explore the possible prevention of genetic diseases before birth. But should they? Currently, the most promising path forward involves editing the genes of human embryos, a procedure threaded with controversy. An article in “Chemical & Engineering News” (C&EN), the weekly newsmagazine of the American Chemical Society (ACS), parses […]
  • Tackling chronic sinusitis by addressing underlying factors
    The stuffy noses and sinus pressure of head colds are uncomfortable, but for most people, they go away within days. For those with chronic sinusitis, however, those symptoms and others drag on for weeks. Now scientists are onto a potential new therapy that could address one of the underlying factors associated with the condition. They […]
  • Implantable “artificial pancreas” could help diabetes patients control their blood sugar
    Living with Type 1 diabetes requires constant monitoring of blood sugar levels and injecting insulin daily. Now scientists are reporting in the American Chemical Society (ACS) journal, “Industrial & Engineering Chemistry Research,” the development of an implantable “artificial pancreas” that continuously measures a person’s blood sugar or glucose level and can automatically release insulin as […]
  • Drug Deactivation program roll out to all facilities for safe disposal of unused prescription medications
    Verde Technologies announced that New Brighton-based Meridian Behavioral Health, the largest for-profit substance abuse and addiction treatment group in Minnesota, has become its most recent partner in the deactivation and safe disposal of prescription medications including methadone. Meridian is the first behavioral health group to roll out the Deterra Drug Deactivation System to all 17 […]
  • Lophius Biosciences introduces T-activated ImmunoScan Cocktail
    Lophius Biosciences announced the commercial launch of T-Track ImmunoScan and T-activated ImmunoScan Cocktail. Based on a proprietary and very specific cocktail of stimulants in combination with the Company’s T-activation technology, T-Track ImmunoScan and T-activated ImmunoScan Cocktail specifically target different cell types involved in both the adaptive and innate immune system. T-Track ImmunoScan and the T-activated […]

Leave a Reply